385 related articles for article (PubMed ID: 9713328)
21. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
22. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
[TBL] [Abstract][Full Text] [Related]
23. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism.
Eizirik DL; Welsh M; Strandell E; Welsh N; Sandler S
Endocrinology; 1990 Nov; 127(5):2290-7. PubMed ID: 2171911
[TBL] [Abstract][Full Text] [Related]
25. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
28. Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets.
Nielsen JH
Endocrinology; 1982 Feb; 110(2):600-6. PubMed ID: 6276141
[TBL] [Abstract][Full Text] [Related]
29. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.
Eizirik DL; Strandell E; Bendtzen K; Sandler S
Diabetes; 1988 Jul; 37(7):916-9. PubMed ID: 3290009
[TBL] [Abstract][Full Text] [Related]
30. [The role of nitric oxide on the functional change of interleukin-1 beta and interleukin-6 induced rat pancreatic islets of Langerhans].
Chen H; Cai D; Wang M; Liu H
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):458-61. PubMed ID: 11798681
[TBL] [Abstract][Full Text] [Related]
31. Effects of interleukin-15 on suppression of rat pancreatic islets in vitro induced by proinflammatory cytokines.
Wallström J; Andersson AK; Sandler S
Immunol Lett; 2003 Aug; 88(2):141-5. PubMed ID: 12880684
[TBL] [Abstract][Full Text] [Related]
32. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro.
Sandler S; Buschard K; Bendtzen K
Immunol Lett; 1994 Jun; 41(1):73-7. PubMed ID: 7959906
[TBL] [Abstract][Full Text] [Related]
33. Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap.
Rydgren T; Bengtsson D; Sandler S
Diabetes; 2006 May; 55(5):1407-12. PubMed ID: 16644698
[TBL] [Abstract][Full Text] [Related]
34. Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets.
Bleich D; Chen S; Bursten SL; Nadler JL
Endocrinology; 1996 Nov; 137(11):4871-7. PubMed ID: 8895359
[TBL] [Abstract][Full Text] [Related]
35. Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.
Welsh M; Welsh N; Bendtzen K; Mares J; Strandell E; Oberg C; Sandler S
Diabetologia; 1995 Feb; 38(2):153-60. PubMed ID: 7536171
[TBL] [Abstract][Full Text] [Related]
36. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat.
Ostenson CG; Khan A; Abdel-Halim SM; Guenifi A; Suzuki K; Goto Y; Efendic S
Diabetologia; 1993 Jan; 36(1):3-8. PubMed ID: 8436249
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
Rydgren T; Sandler S
Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
[TBL] [Abstract][Full Text] [Related]
38. Effects of starvation and different culture conditions on the phospholipid content of isolated pancreatic islets.
Hallberg A
Biochim Biophys Acta; 1984 Dec; 796(3):328-35. PubMed ID: 6391554
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
[TBL] [Abstract][Full Text] [Related]
40. Effects of prolonged exposure in vitro to interferon-gamma and tumour necrosis factor-alpha on nitric oxide and insulin production of rat pancreatic islets.
Sternesjö J; Bendtzen K; Sandler S
Autoimmunity; 1995; 20(3):185-90. PubMed ID: 7578879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
